全文获取类型
收费全文 | 1864篇 |
免费 | 103篇 |
国内免费 | 6篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 48篇 |
妇产科学 | 61篇 |
基础医学 | 260篇 |
口腔科学 | 30篇 |
临床医学 | 165篇 |
内科学 | 400篇 |
皮肤病学 | 22篇 |
神经病学 | 179篇 |
特种医学 | 130篇 |
外科学 | 289篇 |
综合类 | 3篇 |
预防医学 | 112篇 |
眼科学 | 18篇 |
药学 | 124篇 |
中国医学 | 1篇 |
肿瘤学 | 123篇 |
出版年
2023年 | 14篇 |
2022年 | 24篇 |
2021年 | 54篇 |
2020年 | 20篇 |
2019年 | 36篇 |
2018年 | 51篇 |
2017年 | 41篇 |
2016年 | 31篇 |
2015年 | 46篇 |
2014年 | 74篇 |
2013年 | 100篇 |
2012年 | 108篇 |
2011年 | 103篇 |
2010年 | 89篇 |
2009年 | 80篇 |
2008年 | 96篇 |
2007年 | 93篇 |
2006年 | 113篇 |
2005年 | 97篇 |
2004年 | 85篇 |
2003年 | 69篇 |
2002年 | 73篇 |
2001年 | 64篇 |
2000年 | 52篇 |
1999年 | 39篇 |
1998年 | 11篇 |
1997年 | 14篇 |
1996年 | 8篇 |
1995年 | 14篇 |
1994年 | 15篇 |
1993年 | 6篇 |
1992年 | 25篇 |
1991年 | 37篇 |
1990年 | 26篇 |
1989年 | 25篇 |
1988年 | 10篇 |
1987年 | 16篇 |
1986年 | 11篇 |
1985年 | 15篇 |
1984年 | 8篇 |
1983年 | 4篇 |
1982年 | 4篇 |
1980年 | 5篇 |
1979年 | 14篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1974年 | 7篇 |
1973年 | 8篇 |
1970年 | 5篇 |
1967年 | 3篇 |
排序方式: 共有1973条查询结果,搜索用时 15 毫秒
11.
A presenilin 1 mutation (Ser169Pro) associated with early-onset AD and myoclonic seizures 总被引:2,自引:0,他引:2
OBJECTIVE: To characterize the mutation responsible for early-onset AD in a large Spanish kindred. BACKGROUND: Mutations in the presenilin 1 (PS1) gene have been identified and are known to be responsible for 18 to 50% of familial early-onset AD cases. METHODS: Patients were characterized clinically. The proband was further studied with EEG, CSF analysis, CT, brain biopsy, and histology. Other members were studied using EEG, CT, MRI, and SPECT. Genetic analysis of PS1 was performed using PCR amplification of PS1 exons and direct sequencing followed by PS1 modeling of the normal and mutant PS1 proteins. RESULTS: A novel mutation (Ser169Pro) in exon 6 of the PS1 gene was identified in different affected members. The Ser169Pro mutation is located at a site of the PS1 protein that is not a cluster of mutations. The mutation was not present in 100 general population controls and in 50 unrelated sporadic AD cases. The Ser169Pro mutation is associated with generalized myoclonic seizures several years after the initial symptoms of AD, a very early AD onset (< or =35 years), and a rapidly progressive cognitive decline. CONCLUSIONS: The absence of the PS1 Ser169Pro mutation in the general population and in sporadic AD cases together with its detection in the affected members of this kindred suggests that it is a pathogenic mutation. The serine to proline change predicts a kink in the alpha-helix of the transmembrane domain of the PS1 protein that could radically disrupt its normal structure. Further characterization of the effect of this mutation could help identify the function of the PS1 protein and the pathogenic mechanisms of AD. 相似文献
12.
Oliva ML Andrade SA Batista IF Sampaio MU Juliano M Fritz H Auerswald EA Sampaio CA 《Immunopharmacology》1999,45(1-3):145-149
Kunitz type Bauhinia ungulata factor Xa inhibitor (BuXI) was purified from B. ungulata seeds. BuXI inactivates factor Xa and human plasma kallikrein (HuPK) with Ki values of 18.4 and 6.9 nM, respectively. However, Bauhinia variegata trypsin inhibitor (BvTI) which is 70% homologous to BuXI does not inhibit factor Xa and is less efficient on HuPK (Ki = 80 nM). The comparison between BuXI and BvTI reactive site structure indicates differences at Met59, Thr66 and Met67 residues. The hydrolysis rate of quenched fluorescence peptide substrates based on BuXI reactive site sequence, Abz-VMIAALPRTMFIQ-EDDnp (leading peptide), by HuPK and porcine pancreatic kallikrein (PoPK) is low, but hydrolysis is enhanced with Abz-VMIAALPRTMQ-EDDnp, derived from the leading peptide shortened by removing the dipeptide Phe-Ileu from the C-terminal portion, for HuPK (Km = 0.68 microM, k(cat)/Km = 1.3 x 10(6) M(-1) s(-1)), and the shorter substrate Abz-LPRTMQ-EDDnp is better for PoPK (Km = 0.66 microM, k(cat)/Km = 2.2 x 10(3) M(-1) s(-1)). The contribution of substrate methionine residues to HuPK and PoPK hydrolysis differs from that observed with factor Xa. The determined Km and k(cat) values suggest that the substrates interact with kallikreins the same as an enzyme and inhibitor interacts to form complexes. 相似文献
13.
Oliva ML Mendes CR Juliano MA Chagas JR Rosa JC Greene LJ Sampaio MU Sampaio CA 《Immunopharmacology》1999,45(1-3):163-169
Trypsin inhibitors were purified from a saline extract of Bauhinia bauhinioides seeds by ion-exchange column chromatography on DEAE-Sephadex, gel filtration on Superose 12 column, Mono Q ion-exchange chromatography or, alternatively, by affinity chromatography on trypsin-Sepharose. Both B. bauhinioides isolated inhibitors, BbTI-I and BbTI-II, inhibit trypsin being the dissociation constant 0.6 and 0.36 nM, respectively. BbTI-II only inhibits porcine pancreatic kallikrein hydrolysis of H-Pro-Phe-Arg-AMC (Ki 2.0 nM); the bradykinin-containing sequence LGMISLMKRPPGFSPFRSSRI-NH2 and the two kininogen related flanking quenched substrates Abz-MISLMKRP-EDDnp (Ki 2.0 nM) and Abz-FRSSRQ-EDDnp (Ki 2.5 nM). 相似文献
14.
Cell-free 59 kDa immunoreactive integrin-linked kinase: a novel marker for ovarian carcinoma. 总被引:9,自引:0,他引:9
PURPOSE: We reported that the expression of integrin-linked kinase (ILK) is up-regulated in ovarian carcinomas and that ovarian cancer cells have high expression of ILK. In this study, we have examined the expression of cell-free 59 kDa immunoreactive (ir)ILK in the serum and peritoneal fluid (PTF) of patients with ovarian cancer and evaluated its potential as a serum biomarker for early-stage screening and for monitoring clinical status of patients after chemotherapy treatment. EXPERIMENTAL DESIGN: Thirty-six serum specimens, including normal (n = 6), benign (n = 6), borderline (n = 4), grade 1 (n = 5), grade 2 (n = 5), and grade 3 (n = 10), were evaluated for the expression of irILK by Western blotting. The expression of irILK was evaluated in PTF (n = 10) and peritoneal washings from women with benign ovarian cysts (n = 4). In addition, tissue-conditioned medium obtained from the cultures of primary ovarian tumors (n = 9) was examined for the presence of irILK. Finally, the potential of serum irILK as a biomarker for ovarian cancer screening was evaluated by comparison with cancer antigen 125 (CA 125) concentrations in cancer patients before and after chemotherapy. RESULTS: irILK expression was present in normal serum and in serum of patients with benign ovarian tumors. irILK expression was 6-9-fold higher in the serum of patients with grade 1, grade 2, and grade 3 ovarian cancer than in the serum of healthy volunteers and patients with benign ovarian tumors (P < 0.01). Enhanced expression of irILK in the serum of ovarian cancer patients correlated with the concentration of CA 125. High expression of irILK was present in all 10 PTF tested. Tissue-conditioned medium prepared from malignant ovarian tumors had 4-fold more irILK expression than conditioned medium obtained from borderline and benign tumors (P < 0.01). irILK expression in serum of cancer patients was reduced to basal normal levels after six cycles of Taxol/carboplatin and was consistent with the change of CA 125 levels before and after chemotherapy. CONCLUSIONS: These data suggest that irILK is an ovarian tumor-associated antigen and implicates its potential not only as a biomarker for early-stage screening but also as a marker for monitoring the clinical condition of patients after treatment. 相似文献
15.
Lucca R. Policastro Isabela Dolci Andre S. Godoy Jos V. J. Silva Júnior Uriel E. A. Ruiz Igor A. Santos Ana C. G. Jardim Kirandeep Samby Jeremy N. Burrows Timothy N. C. Wells Laura H. V. G. Gil Glaucius Oliva Rafaela S. Fernandes 《Viruses》2022,14(7)
Chikungunya virus (CHIKV) is the causative agent of chikungunya fever, a disabling disease that can cause long-term severe arthritis. Since the last large CHIKV outbreak in 2015, the reemergence of the virus represents a serious public health concern. The morbidity associated with viral infection emphasizes the need for the development of specific anti-CHIKV drugs. Herein, we describe the development and characterization of a CHIKV reporter replicon cell line and its use in replicon-based screenings. We tested 960 compounds from MMV/DNDi Open Box libraries and identified four candidates with interesting antiviral activities, which were confirmed in viral infection assays employing CHIKV-nanoluc and BHK-21 cells. The most noteworthy compound identified was itraconazole (ITZ), an orally available, safe, and cheap antifungal, that showed high selectivity indexes of >312 and >294 in both replicon-based and viral infection assays, respectively. The antiviral activity of this molecule has been described against positive-sense single stranded RNA viruses (+ssRNA) and was related to cholesterol metabolism that could affect the formation of the replication organelles. Although its precise mechanism of action against CHIKV still needs to be elucidated, our results demonstrate that ITZ is a potent inhibitor of the viral replication that could be repurposed as a broad-spectrum antiviral. 相似文献
16.
17.
Francesco Cogliati Dezza Alessandra Oliva Vera Mauro Francesco Eugenio Romani Raissa Aronica Giulia Savelloni Elena Casali Serena Valeri Francesca Cancelli Claudio Maria Mastroianni 《Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive》2022,30(2):211
18.
19.
Claudia Oliva Charles L. Turnbough Jr. John F. Kearney 《Proceedings of the National Academy of Sciences of the United States of America》2009,106(33):13957-13962
Anthrax, a potentially lethal disease of animals and humans, is caused by the Gram-positive spore-forming bacterium Bacillus anthracis. The outermost exosporium layer of B. anthracis spores contains an external hair-like nap formed by the glycoprotein BclA. Recognition of BclA by the integrin Mac-1 promotes spore uptake by professional phagocytes, resulting in the carriage of spores to sites of spore germination and bacterial growth in distant lymphoid organs. We show that CD14 binds to rhamnose residues of BclA and acts as a coreceptor for spore binding by Mac-1. In this process, CD14 induces signals involving TLR2 and PI3k that promote inside-out activation of Mac-1, thereby enhancing spore internalization by macrophages. As observed with mice lacking Mac-1, CD14−/− mice are also more resistant than wild-type mice to infection by B. anthracis spores. Additionally, after B. anthracis spore challenge of CD14−/− mice, interference with the CD14-mediated signaling pathways results in increased mortality. Our results show that the binding and uptake of B. anthracis spores by phagocytic cells is a dynamic process and involves multiple receptors and signaling pathways. 相似文献